Jane Rady

Board Member at CorneaGen

Jane E. Rady serves as senior vice president, corporate strategy and business development at Glaukos. From 2017 to April 2018, she was vice president, business development for Johnson & Johnson Surgical Vision, following the 2017 acquisition by Johnson & Johnson of Abbott Medical Optics, a division of Abbott Laboratories. From 2009 to 2017, she was the divisional vice president, business development for Abbott Medical Optics. From 2002 to 2009, she held several executive leadership positions at Advanced Medical Optics, Inc. (AMO), which was acquired by Abbott Laboratories in 2009. While at AMO, Ms. Rady headed various functions, including business development, strategic planning, research and development, clinical development, regulatory affairs and government affairs. Her prior experiences includes positions at Monsanto Corporation, G.D. Searle and Abbott Laboratories.

Ms. Rady holds a B.S. in biology and an M.S. in molecular biology/microbiology from the University of Illinois and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


CorneaGen

1 followers

CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. Based in Seattle, the company is innovating the next generation of cornea care, from new medical devices and biologics to therapeutics and interventions. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest in innovative products, delivery of the highest quality tissue, surgeon education, and advocacy for patient access and reimbursement policies.


Industries

Employees

51-200

Links